KEY POINTS
  • FDA Commissioner Robert Califf said elevated flu and RSV infection levels among kids are leading to unprecedented demand for children's pain and fever relief medications.
  • Manufacturer Johnson & Johnson said it has ramped up production around the clock to try to meet demand.
  • CVS Health, Walgreens and RiteAid have implemented some purchase restrictions on children's pain and fever relief medications in order to limit supply shortages.

The surge in flu cases and Covid-19 infections this month, along with elevated levels of childhood respiratory syncytial virus, or RSV, infections has caused elevated demand for children's over-the-counter cold and flu medications. The commissioner of the Food and Drug Administration said his agency is working with producers to improve supply but the current demand is unprecedented.  

"We're urging people not to buy more than they need because there is enough to go around for the amount of illness. It's just that the minute it gets shipped out it gets bought. And if people buy more than they need and everybody does that, then people who need the products won't be able to get them," FDA Commissioner Dr. Robert Califf told CNBC.